Clinical Trial Update: Quinoa Improves Glycolipid Metabolism and Glucose Fluctuation Based on β-Cell Function in Early-stage Type 2 Diabetes [NA]

View source ↗

Summary

This clinical trial update indicates that quinoa may improve glycolipid metabolism and glucose variability by influencing β-cell function in early-stage Type 2 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Type 2 Diabetes Mellitus (T2DM) | NA | Status: RECRUITING